Cargando…
The value of decreasing the duration of the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Finding medications or vaccines that may decrease the infectious period of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could potentially reduce transmission in the broader population. We developed a computational model of the U.S. simulating the spread of SARS-CoV-2 and the potentia...
Autores principales: | Lee, Bruce Y., Bartsch, Sarah M., Ferguson, Marie C., Wedlock, Patrick T., O’Shea, Kelly J., Siegmund, Sheryl S., Cox, Sarah N., McKinnell, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7790237/ https://www.ncbi.nlm.nih.gov/pubmed/33411742 http://dx.doi.org/10.1371/journal.pcbi.1008470 |
Ejemplares similares
-
Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention
por: Bartsch, Sarah M., et al.
Publicado: (2020) -
Potential Clinical and Economic Value of Norovirus Vaccination in the Community Setting
por: Bartsch, Sarah M., et al.
Publicado: (2021) -
The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine
por: Bartsch, Sarah M., et al.
Publicado: (2021) -
Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination
por: Bartsch, Sarah M, et al.
Publicado: (2021) -
Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
por: Wedlock, Patrick T., et al.
Publicado: (2021)